284 related articles for article (PubMed ID: 12732246)
1. Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: activating opioid receptors through amygdala-periaqueductal gray pathway.
Xu W; Lundeberg T; Wang YT; Li Y; Yu LC
Neuroscience; 2003; 118(4):1015-22. PubMed ID: 12732246
[TBL] [Abstract][Full Text] [Related]
2. Involvement of calcitonin gene-related peptide and its receptor in anti-nociception in the periaqueductal grey of rats.
Yu LC; Weng XH; Wang JW; Lundeberg T
Neurosci Lett; 2003 Sep; 349(1):1-4. PubMed ID: 12946572
[TBL] [Abstract][Full Text] [Related]
3. Involvement of CGRP and CGRPl receptor in nociception in the basolateral nucleus of amygdala of rats.
Li N; Liang J; Fang CY; Han HR; Ma MS; Zhang GX
Neurosci Lett; 2008 Oct; 443(3):184-7. PubMed ID: 18687383
[TBL] [Abstract][Full Text] [Related]
4. Involvement of opioid receptors in the CGRP-induced antinociception in the nucleus accumbens of rats.
Li L; Wang X; Yu LC
Brain Res; 2010 Sep; 1353():53-9. PubMed ID: 20659434
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive effects of calcitonin gene-related peptide injected into periaqueductal grey of rats with mononeuropathy.
Xu S; Lundeberg T; Yu L
Brain Res; 2000 Mar; 859(2):358-60. PubMed ID: 10719085
[TBL] [Abstract][Full Text] [Related]
6. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.
Tershner SA; Helmstetter FJ
Brain Res; 2000 May; 865(1):17-26. PubMed ID: 10814729
[TBL] [Abstract][Full Text] [Related]
7. Involvement of CGRP and CGRP1 receptor in nociception in the nucleus accumbens of rats.
Li N; Lundeberg T; Yu LC
Brain Res; 2001 May; 901(1-2):161-6. PubMed ID: 11368963
[TBL] [Abstract][Full Text] [Related]
8. Distinct pathways for norepinephrine- and opioid-triggered antinociception from the amygdala.
Maire JJ; Close LN; Heinricher MM; Selden NR
Eur J Pain; 2016 Feb; 20(2):206-14. PubMed ID: 25847835
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin gene-related peptide erases the fear memory and facilitates long-term potentiation in the central nucleus of the amygdala in rats.
Wu X; Zhang JT; Liu J; Yang S; Chen T; Chen JG; Wang F
J Neurochem; 2015 Nov; 135(4):787-98. PubMed ID: 26179152
[TBL] [Abstract][Full Text] [Related]
10. Role of calcitonin gene-related peptide in pain regulation in the parabrachial nucleus of naive rats and rats with neuropathic pain.
Wang LL; Wang HB; Fu FH; Yu LC
Toxicol Appl Pharmacol; 2021 Mar; 414():115428. PubMed ID: 33524449
[TBL] [Abstract][Full Text] [Related]
11. Chronic morphine treatment induces functional delta-opioid receptors in amygdala neurons that project to periaqueductal grey.
Chieng B; Christie MJ
Neuropharmacology; 2009 Sep; 57(4):430-7. PubMed ID: 19580818
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive effects of galanin in the central nucleus of amygdala of rats, an involvement of opioid receptors.
Jin WY; Liu Z; Liu D; Yu LC
Brain Res; 2010 Mar; 1320():16-21. PubMed ID: 20051236
[TBL] [Abstract][Full Text] [Related]
13. Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone.
Huang Y; Brodda-Jansen G; Lundeberg T; Yu LC
Brain Res; 2000 Aug; 873(1):54-9. PubMed ID: 10915810
[TBL] [Abstract][Full Text] [Related]
14. Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems.
Ma W; Chabot JG; Powell KJ; Jhamandas K; Dickerson IM; Quirion R
Neuroscience; 2003; 120(3):677-94. PubMed ID: 12895509
[TBL] [Abstract][Full Text] [Related]
15. Opioid antagonists naloxone, beta-funaltrexamine and naltrindole, but not nor-binaltorphimine, reverse the increased hindpaw withdrawal latency in rats induced by intrathecal administration of the calcitonin gene-related peptide antagonist CGRP8-37.
Yu LC; Hansson P; Lundeberg T
Brain Res; 1995 Nov; 698(1-2):23-9. PubMed ID: 8581488
[TBL] [Abstract][Full Text] [Related]
16. Characterization of rat prepro-orphanin FQ/nociceptin((154-181)): nociceptive processing in supraspinal sites.
Rossi GC; Pellegrino M; Shane R; Abbadie CA; Dustman J; Jimenez C; Bodnar RJ; Pasternak GW; Allen RG
J Pharmacol Exp Ther; 2002 Jan; 300(1):257-64. PubMed ID: 11752124
[TBL] [Abstract][Full Text] [Related]
17. Periaqueductal gray calcitonin gene-related peptide modulates trigeminovascular neurons.
Pozo-Rosich P; Storer RJ; Charbit AR; Goadsby PJ
Cephalalgia; 2015 Dec; 35(14):1298-307. PubMed ID: 25792688
[TBL] [Abstract][Full Text] [Related]
18. Plastic changes of calcitonin gene-related peptide in morphine tolerance: behavioral and immunohistochemical study in rats.
Zhou X; Li JJ; Yu LC
J Neurosci Res; 2003 Nov; 74(4):622-9. PubMed ID: 14598307
[TBL] [Abstract][Full Text] [Related]
19. Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala.
Finnegan TF; Chen SR; Pan HL
J Pharmacol Exp Ther; 2005 Feb; 312(2):441-8. PubMed ID: 15388784
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-D-aspartate receptor agonism and antagonism within the amygdaloid central nucleus suppresses pain affect: differential contribution of the ventrolateral periaqueductal gray.
Spuz CA; Tomaszycki ML; Borszcz GS
J Pain; 2014 Dec; 15(12):1305-18. PubMed ID: 25261341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
